Role of paxillin-associatcd ARFGAPs in cell migration.
Role of paxillin-associatcd ARFGAPs in cell migration.
批准号:
12480219
负责人:
SABE Hisataka
金额:
$9.15万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2001
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ARF6 regulates endosomal recycling. We have shown that PAG3/Papα/KIAA0400 acts as a GTPase-activation protein (GAP) specific for ARF6.We study here molecular mechanims how PAG3 is involved in endosomal recycling to be an ARF6GAP. We found that PAG3, via its proline-rich region, binds to the src homology 3 (SH3) domain of several components of the endocytic machinery, and analysed its interaction with amphiphysin IIa. PAG3 existed at ARF6(Q67L)-positive membrane ruffles colocalized with amphyphysin Ha, but the majority exists at intracellular tubulovesicular structure. Overexpression of the amphiphysin ha SH3 domain is known to block endocytosis. Likewise, overexpression of the proline-rich region of PAG3 blocked both clathrin-dependent and independent endocytosis, while mutations of amino acids essential for the binding abolished such blockage. The SH3 domain of amphiphysin IIa. also binds to dynamin, a mechano-enzyme essential for the late step of endocytosis. We found that PAG3 exhibits almost one order of magnitude higher affinity than that of dynamin towards amphiphysin ha. We also demonstrated that PAG3 can be phosphorylated by a protein tyrosine kinase, Pyk2, but not by its close relative Fak ; and this phosphorylation inhibits the association with amphiphysin ha. With further results, we propose that PAG3 recruits amphiphysin ha to the plasma membrane, probably through interaction with the activity of GTP-bound Arf6 ; and external stimuli triggering endocytosis evoke tyrosine phosphorylation of PAG3, the phosphorylated PAG3 then releases amphiphysin ha to associate with components of endocytic machinery such as dynamin.
期刊论文(86)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Yagi, R., Ishimaru, S., Yano, H., Gaul, U., Hanafusa, H. and Sabe, H.: "A novel muscle LIM-only protein is generated from paxillin gene locus in Drosophila."EMBO J.. 2(9). 814-820 (2001)
Yagi, R.、Ishimaru, S.、Yano, H.、Gaul, U.、Hanafusa, H. 和 Sabe, H.:“果蝇中的桩蛋白基因座产生了一种新型肌肉 LIM 蛋白。”EMBO J
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
H.Yano,H.Uchida,T.Iwasaki,M.Mukai,H.Akedo,K.Nakamura,S.Hashimoto & H.Sabe.: "Paxillin αand Crk-associated substrate exert opposing effects on cell migration and contact inhibition of growth through tyrosine phosphorylation."Proc.Natl.Acad.Sci.USA. 97・16.
H. Yano、H. Uchida、T. Iwasaki、M. Mukai、H. Akedo、K. Nakamura、S. Hashimoto 和 H. Sabe.:“Pacillin α 和 Crk 相关底物对细胞迁移和接触抑制发挥相反作用通过酪氨酸磷酸化生长。“Proc.Natl.Acad.Sci.USA. 97・16。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Woods, AJ., Roberts, MS., Choudhary, J., Barry, ST., Mazaki, Y., Sabe, H., Morley, SJ., Critchley, DR., Norman, JC.: "Paxillin associates with poly(A)-binding protein 1 at the dense endoplasmic reticulum and the leading edge of migrating cells"J Biol Chem
Woods, AJ.、Roberts, MS.、Choudhary, J.、Barry, ST.、Mazaki, Y.、Sabe, H.、Morley, SJ.、Critchley, DR.、Norman, JC.:“Paxillin 与聚
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Hashimoto, S., Tsubouchi, A., Mazaki, Y., Sabe, H.: "Interaction of paxillin with p21-activated kinase(PAK)Association of paxillin alpha with the kinase-inactive and the Cdc42-activated forms of PAK3"J.Biol.Chem.. 276・8. 6037-6045 (2001)
Hashimoto, S.、Tsbouchi, A.、Mazaki, Y.、Sabe, H.:“桩蛋白与 p21 激活激酶 (PAK) 的相互作用、桩蛋白 α 与激酶失活和 Cdc42 激活形式的 PAK3 的关联”生物化学杂志 276・8. (2001)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
A.Kondo,S.Hashimoto,H.Yano,K,Nagayama,Y.Mazaki & H.Sabe.: "A new paxillin-binding protein, PAG3/Papα/KIAA0400, bearing an Arf GTPaseactivating protein activity is involved in paxillin recruitment to focal adhesions and cell migration."Mol.Biol.Cell. 11・4.
A. Kondo、S. Hashimoto、H. Yano、K、Nagayama、Y. Mazaki 和 H. Sabe.:“一种新的桩蛋白结合蛋白 PAG3/Papα/KIAA0400,具有 Arf GTP 酶激活蛋白活性,参与桩蛋白招募粘着斑和细胞迁移。“Mol.Biol.Cell.11・4。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 39 条
Invasiveness acquired during EMT
-
批准号:20247027
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$20.63万
-
财政年份:2008
-
负责人:SABE Hisataka
-
依托单位:
Arf GTPases in cell migration, invasion, and directional sensing and persistency
-
批准号:18370082
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.21万
-
财政年份:2006
-
负责人:SABE Hisataka
-
依托单位:
Mechanisms regulating cell adhesion activities in tumor progression
-
批准号:17014083
-
项目类别:Grant-in-Aid for Scientific Research on Priority Areas
-
资助金额:$44.74万
-
财政年份:2005
-
负责人:SABE Hisataka
-
依托单位:
Cell motility and the backward bulk flow of the plasma membrane components
-
批准号:14380340
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$9.73万
-
财政年份:2002
-
负责人:SABE Hisataka
-
依托单位:
Role of paxillin isoforms and their tyrosine phosphorylation in cell migration.
-
批准号:10480199
-
项目类别:Grant-in-Aid for Scientific Research (B).
-
资助金额:$8.45万
-
财政年份:1998
-
负责人:SABE Hisataka
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于Nrf2介导ROS-自噬信号通路靶向Paxillin调控黏着斑探究三芪口服 液治疗膜性肾病的作用机制
-
批准号:82305132
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:王晓婉
-
依托单位:
Paxillin调控微丝参与小鼠卵母细胞纺锤体迁移的机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:汪玥
-
依托单位:
WNT4通过调控FAK/Paxillin在结直肠癌侵袭转移中的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:
-
依托单位:
CD9/Paxillin调节生物电场介导的表皮细胞方向性迁移的作用及机制研究
-
批准号:82072172
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2020
-
负责人:江旭品
-
依托单位:
CircFUT8竞争性结合miR-361-3p调控Paxillin介导胰腺癌吉西他滨耐药的机制研究
-
批准号:81903721
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2019
-
负责人:杜玥
-
依托单位:
Paxillin调控肝星状细胞自噬与凋亡平衡在肝纤维化中的作用研究
-
批准号:LY19H030013
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2018
-
负责人:马锐
-
依托单位:
长链非编码RNA KCNQ1OT1通过调控Paxillin表达影响肿瘤巨噬细胞M2型极化介导的结肠癌转移的分子机制研究
-
批准号:81802859
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2018
-
负责人:张玲利
-
依托单位:
膜联蛋白A2调控Robo4-paxillin-ARF6通路对创伤性血脑屏障损伤的保护作用及机制研究
-
批准号:81703498
-
项目类别:青年科学基金项目
-
资助金额:20.1万元
-
批准年份:2017
-
负责人:李汶潞
-
依托单位:
Paxillin多靶点、多通路促进高尔基体再定位在人胰腺癌细胞再定向运动中的机制研究
-
批准号:81602116
-
项目类别:青年科学基金项目
-
资助金额:17.0万元
-
批准年份:2016
-
负责人:慕刚刚
-
依托单位:
ARHI与Paxillin相互作用抑制FAK自磷酸化对胃癌细胞恶性表型的影响及机制研究
-
批准号:81502084
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2015
-
负责人:唐海灵
-
依托单位: